Asset Details
Do you wish to reserve the book?
Lessons Learned from West Nile Virus Infection:Vaccinations in Equines and Their Implications for One Health Approaches
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Lessons Learned from West Nile Virus Infection:Vaccinations in Equines and Their Implications for One Health Approaches
Do you wish to request the book?
Lessons Learned from West Nile Virus Infection:Vaccinations in Equines and Their Implications for One Health Approaches
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Lessons Learned from West Nile Virus Infection:Vaccinations in Equines and Their Implications for One Health Approaches
2024
Overview
Humans and equines are two dead-end hosts of the mosquito-borne West Nile virus (WNV) with similar susceptibility and pathogenesis. Since the introduction of WNV vaccines into equine populations of the United States of America (USA) in late 2002, there have been only sporadic cases of WNV infection in equines. These cases are generally attributed to unvaccinated and under-vaccinated equines. In contrast, due to the lack of a human WNV vaccine, WNV cases in humans have remained steadily high. An average of 115 deaths have been reported per year in the USA since the first reported case in 1999. Therefore, the characterization of protective immune responses to WNV and the identification of immune correlates of protection in vaccinated equines will provide new fundamental information about the successful development and evaluation of WNV vaccines in humans. This review discusses the comparative epidemiology, transmission, susceptibility to infection and disease, clinical manifestation and pathogenesis, and immune responses of WNV in humans and equines. Furthermore, prophylactic and therapeutic strategies that are currently available and under development are described. In addition, the successful vaccination of equines against WNV and the potential lessons for human vaccine development are discussed.
Publisher
MDPI AG
Subject
/ Disease
/ Diseases
/ equines
/ France
/ Horse Diseases - prevention & control
/ Horses
/ Humans
/ immunity
/ Israel
/ Romania
/ Serology
/ United States - epidemiology
/ Vaccines
/ Viruses
/ West Nile Fever - epidemiology
/ West Nile Fever - immunology
/ West Nile Fever - prevention & control
/ West Nile Fever - transmission
